Abeona Therapeutics Inc (NASDAQ: ABEO) is 0.60% higher on its value in year-to-date trading and has touched a low of $2.83 and a high of $9.01 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ABEO stock was last observed hovering at around $5.42 in the last trading session, with the day’s loss setting it -0.38%.
Currently trading at $5.04, the stock is 7.72% and 11.90% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.1 million and changing -7.01% at the moment leaves the stock -3.83% off its SMA200. ABEO registered 29.23% gain for a year compared to 6-month loss of -1.95%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 11.75% gain in the last 1 month and extending the period to 3 months gives it a -36.44%, and is -2.89% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.50% over the week and 6.01% over the month.
Abeona Therapeutics Inc (ABEO) has around 84 employees, a market worth around $206.44M and $3.50M in sales. Profit margin for the company is -2190.26%. Distance from 52-week low is 78.09% and -44.06% from its 52-week high. The company has generated returns on investments over the last 12 months (-578.82%).
The EPS is expected to grow by 31.82% this year
The shares outstanding are 40.96M, and float is at 38.73M with Short Float at 8.68%.
Abeona Therapeutics Inc (ABEO) Insider Activity
The most recent transaction is an insider sale by Alvino Mark, the company’s Director. SEC filings show that Alvino Mark sold 25,890 shares of the company’s common stock on Jun 18 ’24 at a price of $4.51 per share for a total of $0.12 million. Following the sale, the insider now owns 36926.0 shares.
Abeona Therapeutics Inc disclosed in a document filed with the SEC on Jun 18 ’24 that Silverstein Christine Berni (Director) sold a total of 25,821 shares of the company’s common stock. The trade occurred on Jun 18 ’24 and was made at $4.51 per share for $0.12 million. Following the transaction, the insider now directly holds 62063.0 shares of the ABEO stock.
Still, SEC filings show that on May 16 ’24, Alland Leila (Director) acquired 11,000 shares at an average price of $4.71 for $51799.0. The insider now directly holds 82,857 shares of Abeona Therapeutics Inc (ABEO).
